Gannon Steven

Xenon Pharmaceuticals Inc. · Director

Gannon Steven is listed in filings as Director at Xenon Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 3, 2026, including sale activity. Recent filings connect the profile to Xenon Pharmaceuticals Inc. (XENE). The current snapshot covers public activity from May 16, 2025 to Jun 3, 2026. Reported amounts are shown as $561.7K to $25.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.